IFNL1 and rheumatoid arthritis: Furthermore, our in vitro studies revealed that recombinant IL-29 can stimulate MH7A cells, a human synovial fibroblast cell line, for enhanced production of proinflammatory cytokines, indicating a novel function of IL-29 in driving synovial inflammation during RA development.